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Objectives: To identify the role of tumor necrosis factor-a (TNF-a) and soluble
intercellular adhesion molecule (sICAM) in the process of coronary artery diseases
and assess the correlation between TNF-a and sICAM levels and the severity of
coronary artery diseases (CAD).
Methods: The serum concentration of TNF-a and sICAM were measured in pe-
ripheral blood (venae radiales) of 30 patients with acute myocardial infarction
(AMI),30 with stable angina pectoris (AP),and 30 control cases (Con) who were
healthy subjects. For patients with AMI, the blood samples were obtained in 24 hours
after acute myocardial infarction. For patients with AP, the blood samples were ob-
tained in 24 hours after the latest angina pectoris. All the blood samples were obtained
in the fasting state. The serum concentration of TNF-a and sICAM were measured by
enzyme linked immunosorbent assay. The general data were recorded, such as gender,
age, history of disease, and smoking. One-way ANOVA and Pearson correlation
coefﬁcient were used to analyze the results.
Results: There was no signiﬁcant difference in gender, age, history of disease, and
smoking among the three groups (P>0.05).The TC, TG, LDL levels of AMI and
AP groups were signiﬁcantly higher than the Con group (P<0.05), but there was
no signiﬁcant difference between AMI and AP group (P>0.05). The serum con-
centrations of TNF-a and sICAM (ug/l) in patients with AMI were higher than the
AP and the Con subjects (P<0.01).And the AP group was higher than the Con
group (P<0.01). (TNF-a: AMI 0.460.44, AP 0.0760.023, Con 0.0590.012,
sICAM: AMI 1.370.44, AP 0.750.25, Con 0.470.23) (P<0.01). In the three
groups, the levels of TNF-a and sICAM were positively correlated (r¼0.634,
P<0.01).
Conclusions: TNF-a and sICAM were involved in the process of coronary artery
diseases. They were positively correlated with the severity of CAD.
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Objectives: Macrophage migration inhibitory factor (MIF) has been implicated in the
pathogenesis of coronary artery disease (CHD). We explored the plasma MIF level
and studied its predictive value of major adverse cardiac events in CHD patients.
Methods: There were 126 patients with acute myocardial infaction (AMI), 154 pa-
tients with unstable angina (UA), 40 patients with stable angina (SA) who were
recruited from First Afﬁliate Hospital of Xi’an Jiaotong University from January 2012
to December 2013. At the same time, 116 control patients with coronary adiography
negative and without heart disease history were selected. The next day morning,
fasting venous blood were collected. Plasma MIF levels were measured by ELISA. All
patients were followed up for a period of around 1 year. The endpoint events were
deﬁned as major adverse cardiac events (MACE), including cardiac death, non-fatal
myocardial infarction and target vessel revascularization (TVR).
Results: The plasma MIF levels were signiﬁcantly higher in CHD than in control
patients (11.12 (6.81, 11.86) vs. 4.42 (3.15, 6.50) ng/ml. Meanwhile, plasma
MIF levels were much higher in AMI than UA (17.51 (13.28, 26.90) vs. 7.80
(5.41, 11.66) ng/ml, P<0.01) and SA patients (17.51 (13.28,26.90) vs. 7.68
(4.60,10.98) ng/ml, P<0.01). During the period of follow up, 17 patients with AMI
or UA who had lower MIF level experienced endpoint events. Multivariate logistic
regression analysis revealed that the increment of MIF levels (per 10 ng/ml MIF)
resulted in a markedly reduced risk for MACE (OR¼0.78, 95% CI 0.61-1.04)
in AMI patients. Kaplan-Meier plots for MACE-free survivals showed a signiﬁcant
difference between higher and lower MIF levels in AMI patients
(Logrank¼23.751, P<0.01). Corrected by traditional cardiovascular risk factors,
circulating MIF in acute stage still played a notable protective effect in AMI pa-
tients (HR¼0.78, 95% CI 0.61-1.04). The c-statistic showed that the predictive
value of MIF level was incremental over that of the conventional predictors for
coronary events in AMI group.
Conclusions: Plasma MIF levels are signiﬁcant higher in CHD group, especially in
AMI patients. AMI patients with much higher MIF level in acute stage have fewer
MACE events than those patients who have lower MIF level. Acute stage MIF level
can be an independent prognostic predictive factor for AMI patients.
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Objectives: The effects of impaired glucose metabolism (IGM) on heart rate vari-
ability (HRV) in patients with coronary atherosclerotic heart disease have been lessC122 JACC Vol 64/16/Suppl C j October 16–1studied. The study aimed to compare the heart rate, HRV and the circadian variation of
heart rate among the patients with combined coronary atherosclerotic heart disease and
impaired glucose metabolism, the patients with coronary atherosclerotic heart disease,
and the normal control; to investigate the relation between different levels of HbA1c
and the parameters of HRV in coronary atherosclerotic heart disease patients with
IGM.
Methods: The study population consisted of three groups: 129 patients with
combined angiographically documented coronary atherosclerotic heart disease and
IGM (Group CAD + IGM), 207 patients with angiographically documented coro-
nary atherosclerotic heart disease (Group CAD), and 76 normal subjects (Group
Control). We divided the group CAD + IGM into 2 subgroups according to the
levels of HbA1c (Group HbA1c7.0%, and Group HbA1c<7.0%). All subjects’
clinical data, fasting blood results, LVEF, and the features of coronary artery le-
sions by coronary angiography or coronary 320-slice CT were collected. All sub-
jects performed a 24-hour dynamic electrocardiogram monitoring. The 24-hour
means heart rate, time domain and frequency domain parameters of HRV were
collected.
Results: There was a signiﬁcant decline of 24-hour values of all HRV parameters in
group CAD + IGM vs group CAD and group Control, with the highest in controls, the
intermediate in group CAD, and the lowest value in group CAD + IGM. SDNN,
SDANN, SDNN-Index, RMSSD, PNN50 and TP, VLF, LF, HF were signiﬁcantly
different among these three groups (P<0.05). The mean heart rate of group CAD +
IGM, group CAD, and group Control showed a trend of gradually reducing. The mean
heart rate presented a marked day-night pattern in all three groups, with a decline in
nighttime and a increase in daytime. The variation trend among three groups had a
signiﬁcant difference (P<0.05).The 24-hour values of all HRV parameters between
the subgroup HbA1c7.0% and subgroup HbA1c<7.0% did not show signiﬁcant
differences.
Conclusions: Patients with coronary atherosclerotic heart disease present a cardiac
autonomic nervous dysfunction. Impaired glucose metabolism can make a further
exacerbation on the cardiac autonomic nervous dysfunction of these coronary
atherosclerotic heart disease patients. The mean heart rate present a marked day-night
pattern in all three groups, with a decline in nighttime and a increase in daytime. But
the nighttime heart rate in group Control decreases to a signiﬁcantly lower level than
those in the other two groups. The 24-hour values of all HRV parameters between the
subgroup HbA1c7.0% and subgroup HbA1c<7.0% do not show signiﬁcant
differences.
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Objectives: To provide a theoretical basis for clinical prevention and treatment of
coronary heart disease in patients with different gender by analyzing the gender dif-
ferences in patients with risk factors of ACS.
Methods: The clinical data and angiographic results of 1269 ACS patients
were collected from March 2012 to January 2014, including 901 male patients and
368 female patients. The patients were grouped by age into middle-aged group
(age 55) and older-aged group (age>55), and grouped by blood lipid levels
into normal HDL - C group (0.91 mmol/L) and HDL - C lower group (< 0.91
mmol/L), while also divided into non-HDL-C<3.37 mmol/L group and non-
HDL-C3.37 mmol/L group. The traditional CHD risk factors (including age,
smoking, blood pressure, blood glucose, BMI, family history) and coronary
angiographic changes of these patients are analyzed and compared between
different genders.
Results: (1) The age of female ACS patients is 68.08.5 years old and that of the
male patients is 62.311.2 years old, so the women’s onset age of acute coronary
syndrome (ACS) is older than men’s. (2) The incidence of women with hyper-
tension and diabetes is higher than that of men, and the proportion of men with a
smoking history is signiﬁcantly higher than that of women (P<0.05). (3) According
to the division standard of Chinese adults’ Blood lipid control guide, the TC at the
appropriate level accounted for 73.9% of men, which accounted for 60.6% of
women. The TG at the appropriate level accounted for 56.9% of men, which
accounted for 45.9% of women. The LDL-C at the appropriate level accounted for
65.3% of men, which accounted for 57.6% of women. The HDL-C at the appro-
priate level accounted for 33.4% of men, which accounted for 55.6% of women.
(4). LDL-C/HDL-C of elder women is higher than that of middle-aged women.
HDL-C and Apo-a of elder men is higher than that of middle-aged men. (5) The
proportion of normal HDL-C both in the middle-aged and elder-aged group of
women is higher than that of men, and the proportion of men’s lower HDL-C level
is higher than that of women’s (P<0.05). There is no gender difference in corre-
lation between HDL-C and the severity of coronary artery lesions. (6) In age>55
patients, there have signiﬁcant gender differences between non-HDL-C<3.37
mmol/L and non-HDL-C3.37 mmol/L group. But in age55 patients, there has
no difference in correlation between non-HDL-C and the severity coronary artery
lesions.
Conclusions: (1) The ACS incidence of women in age55 is lower than that in the
same-aged men; however the ACS incidence of women in age>55 signiﬁcantly
increased, even higher than that in the same-aged men. (2) The effect of hypertension
and diabetes for women is larger than that for men, while the effect of smoking history
for men is larger than that for women. There is no gender difference between CHD9, 2014 j GW-ICC Abstracts/Cardiovascular Disease Clinical Research
